Pay in 4 interest-free payments of $7.09 Learn more
Ships within 48 hours · Estimated delivery Aug 24 - Aug 29
Tesaglitazar, as add-on therapy to sulphonylurea, dose-dependently improves glucose and lipid abnormalities in patients with type 2 diabetes
Scheduling steps may vary
The BALANCE model would have allowed Part D plans to opt into the program to provide coverage for GLP-1 drugs for weight loss for their enrollees
Building a thigh injection rotation schedule Rotation is not optional
Gastrointestinal effects Nausea is the most commonly reported side effect, especially during the first few weeks and after each dose increase
US$ 22.35
US$ 24.94
US$ 25.06
US$ 26.91
